2025-12-18T12:43:39.792765+0530 | INFO | Session: 386ff41a-a825-4173-b283-ac884a0c05c8 | User: hey | Source: Pharma_Clinical_Trial_AllDrugs.xlsx | Retrieved: 3 | Clarification: False | Unknown: False | Safety: False
2025-12-18T12:44:55.108450+0530 | INFO | Session: 6da222f3-4676-4343-a310-1d0944ccf265 | User: What AEs are reported for Pembrolizumab in melanoma? | Source: Pharma_Clinical_Trial_AllDrugs.xlsx | Retrieved: 3 | Clarification: False | Unknown: False | Safety: False
2025-12-18T12:46:50.969241+0530 | INFO | Session: 31b6dcf7-67dc-4fc4-b20c-5ae0c2cc3877 | User: What's the recommended dose for Metformin? | Source: Pharma_Clinical_Trial_AllDrugs.xlsx | Retrieved: 3 | Clarification: False | Unknown: False | Safety: False
2025-12-18T12:46:59.084038+0530 | INFO | Session: 31b6dcf7-67dc-4fc4-b20c-5ae0c2cc3877 | User: What AEs are reported for Pembrolizumab in melanoma? | Source: Pharma_Clinical_Trial_AllDrugs.xlsx | Retrieved: 3 | Clarification: False | Unknown: False | Safety: False
2025-12-18T12:47:06.060727+0530 | INFO | Session: 31b6dcf7-67dc-4fc4-b20c-5ae0c2cc3877 | User: What AEs are reported for Pembrolizumab in melanoma? | Source: Pharma_Clinical_Trial_AllDrugs.xlsx | Retrieved: 3 | Clarification: False | Unknown: False | Safety: False
2025-12-18T12:47:45.213549+0530 | INFO | Session: 31b6dcf7-67dc-4fc4-b20c-5ae0c2cc3877 | User: What AEs are reported for Pembrolizumab in melanoma? | Source: Pharma_Clinical_Trial_AllDrugs.xlsx | Retrieved: 3 | Clarification: False | Unknown: False | Safety: False
